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Introduction: The 2004 World Health Organization classification of 
lung cancer contained three major forms of non–small-cell lung cancer: 
squamous cell carcinoma (SqCC), adenocarcinoma (AdC), and large 
cell carcinoma. The goal of this study was first, to assess the reproduc-
ibility of a set of histopathological features for SqCC in relation to other 
poorly differentiated non–small-cell lung cancers and second, to assess 
the value of immunohistochemistry in improving the diagnosis.
Methods: Resection specimens (n = 37) with SqCC, large cell 
carcinoma, basaloid carcinoma, sarcomatoid carcinoma, lympho-
epithelial-like carcinoma, and solid AdC, were contributed by the 
participating pathologists. Hematoxylin and eosin (H&E) stained 
slides were digitized. The diagnoses were evaluated in two ways. 
First, the histological criteria were evaluated and the (differential) 
diagnosis on H&E alone was scored. Second, the added value of 
additional stains to make an integrated diagnosis was examined.
Results: The histologic criteria defining SqCC were consistently used, 
but in poorly differentiated cases they were infrequently present, render-
ing the diagnosis more difficult. Kappa scores on H&E alone were for 
SqCC 0.46, large cell carcinoma 0.25, basaloid carcinoma 0.27, sarco-
matoid carcinoma 0.52, lymphoepithelial-like carcinoma 0.56, and solid 
AdC 0.21. The κ score improved with the use of additional stains for 
SqCC (combined with basaloid carcinoma) to 0.57, for solid AdC to 0.63.
Conclusion: The histologic criteria that may be used in the dif-
ferential diagnosis of poorly differentiated lung cancer were more 
precisely refined. Furthermore, additional stains improved the repro-
ducibility of histological diagnosis of SqCC and AdC, uncovering 
information that was not present in routine H&E stained slides.
Key Words: Non–small-cell lung cancer, Pathology, Reproducibility.
(J Thorac Oncol. 2014;9: 1354–1362)
The 2004 World Health Organization (WHO) classification of lung cancer contained three major forms of non–small-cell 
lung cancer (NSCLC): squamous cell carcinoma (SqCC), adeno-
carcinoma (AdC), and large cell carcinoma.1 With an update to 
the classification of AdC, being published by the International 
Association for the Study of Lung Cancer/American Thoracic 
Society/European Respiratory Society containing additional 
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changes to terminology make the classification more relevant to 
clinical management and the molecular biology of AdC.2 Following 
this, the IASLC pathology committee published a reproducibility 
study supporting its usage in a routine diagnostic setting3 and the 
accuracy in distinguishing better differentiated SqCCs from AdCs 
has been repeatedly demonstrated elsewhere.4–7
However, there are a few data on the reproducibility 
between pathologists in relation to more poorly differentiated 
tumors, especially in small biopsies.8 Specifically, in this set-
ting, the differential diagnosis often lies between a poorly dif-
ferentiated SqCC and large cell carcinoma, basaloid carcinoma, 
sarcomatoid or pleomorphic carcinoma, lymphoepithelial-like 
carcinoma (LELC), and solid AdC. Until recently, there was no 
clinical imperative for further differentiation, with cases being 
classified as NSCLC-not otherwise specified (NOS). However, 
with advances in chemotherapy, there is an increasing need for 
accurate subdivision, even in these more poorly differentiated 
neoplasms.9 Current WHO criteria are purely morphologic for 
SqCC, these being the presence of keratinization and/or the 
presence of intercellular bridges, the latter criterion being espe-
cially relevant in more poorly differentiated tumors.
Therefore, the goal of this study was first, to assess the 
reproducibility of a set of histopathological features for SqCC 
in relation to other poorly differentiated NSCLCs, using 
a panel of pulmonary pathologists from three continents. 
Second, we assessed the value of immunohistochemistry 
(IHC) in improving the diagnosis as an ancillary tool.
MATERIALS AND METHODS
Resection specimens (n = 80) with SqCC (well and poorly 
differentiated), and other cases with diagnosis according to the 
WHO classification 20041 (large cell carcinoma, basaloid carci-
noma, sarcomatoid or pleomorphic carcinoma, LELC, and AdC 
with a solid pattern), were contributed by 10 participating pathol-
ogists. Hematoxylin and eosin (H&E)–stained slides were sent 
to the Tsukuba Critical Path Research and Education Integrated 
Learning Center at the University of Tsukuba. NanoZoomer 2.0-
HT:C9600-13 system was used to scan the slides, Hamamatsu 
Photonics, Hamamatsu, Japan. The digitized cases were made 
available on the Internet for reading by the participants.
In this pilot study, 19 histological criteria were consid-
ered by the IASLC pathology committee as of possible value 
in the discrimination of poorly differentiated tumors and, in 80 
cases, were scored for their presence, as described in Table 1, 
with a preferred diagnosis made by 12 pathologists, revealing 
a low κ score (data not shown).
After this pilot study, the histological criteria were re-
evaluated. Six of the criteria were discarded as they were not 
informative (their presence or absence was not discriminating 
for any diagnostic category) for the cases, leaving 12 criteria 
to be used for further evaluation (printed in bold in Table 1). 
Detailed images were taken from the digitally scanned slides, 
placed in a Powerpoint file as examples, and consensus defi-
nitions of individual histological features were agreed upon 
(Table 2).
To facilitate the application of the WHO criteria, a flow 
chart was made, see Figure 1.
TAbLE 1.  The Criteria Evaluated in the First Round Are Shown and Scored for Each Case as One of the Three Choices
Criterion
1 Keratinization Yes No Uncertain
2 Pearl formation Yes No Uncertain
3 Intercellular bridges Yes No Uncertain
4 Peripheral palisading of nuclei Yes No Uncertain
5 Intercellular gaps Yes No Uncertain
6 Sheets of polygonal cells Yes No Uncertain
7 Spindle cells Yes No Uncertain
8 Giant cells Yes No Uncertain
9 Pleomorphic cells Yes No Uncertain
10 Cell borders Rarely seen In between Sharp
11 Nuclei Monomorphic In between Pleomorphic
12 Nuclear moulding Yes No Uncertain
13 Chromatin Finely granular In between Vesicular
14 Nucleoli Inconspicuous In between Prominent
15 Glassy eosinophilic cytoplasm Yes No Uncertain
16 Intracytoplasmic vacuoles Yes No Uncertain
17 Mitoses Low <1/10 HPF = ~0.5 mm In between Many >1–2/HPF = ~0.5 mm
18 Mitoses Absent In between Prominent
19 Lymphocytic infiltrate Absent
Present in stroma Between tumor cells In both compartments
 Comment: [max500 characters]
In the second round only the bold criteria were scored.
HPF, high power field.
1356 Copyright © 2014 by the International Association for the Study of Lung Cancer
Thunnissen et al. Journal of Thoracic Oncology ®  •  Volume 9, Number 9, September 2014
To assess the reproducibility of diagnosis in poorly differ-
entiated tumors, a ring study was performed in which 37 of the 
initial 80 digitized cases were read in a second ring study by 16 
pathologists. The reduction to 37 cases was based on the informa-
tion from the pilot study that κ scores did not essentially change 
by reading more cases. The interval between the pilot study and 
this ring study was 12 months.
In contrast to the pilot study, two levels of diagnosis 
were evaluated. First, the (differential) diagnosis on H&E 
alone was scored. Subsequently, the immunohistochemical 
information (i.e., the result from the submitting pathologist 
regarding TTF1, mucin, and p63/p40) was provided, allowing 
the pathologist to make a “second level” integrated diagnosis 
based on H&E plus additional stains, should they wish.
Statistics
The distribution of the readers’ diagnoses was compared 
with the original submitting pathologist’s diagnosis. The κ scores 
were calculated in two different ways: (1) between all diagnos-
tic categories for all possible combinations of pathologists and 
diagnostic categories and (2) for each individual diagnostic cat-
egory versus all the other diagnostic categories combined. For 
each pathologist, the sensitivity and specificity of the score, for 
TAbLE 2.  Definitions for Individual Criteria Formulated after First Ring Study
Intercellular bridges The gaps that have real bridges are often relatively narrow, are always bordered by cytoplasm, usually plenty of eosinophilic, glassy 
stuff, and show a constant width. Intercellular bridges are typically seen between elongated cells and are best confirmed at 40× 
microscope objective (not 20×). The intercellular bridges show several (at least three) connections across the intercellular gap 
and have a regular quality, similar to the spokes of a wheel or the parallel rungs of a ladder, see Figure 1. In very well-fixed 
specimens, one may see a tiny dot in the center of the strand between the two adjacent cells, which represents the macula adherens 
(desmosome), but this is uncommonly seen.
Intercellular bridges are a defining criterion for squamous differentiation. They are also prone to overinterpretation, especially when 
the gaps are not tight and parallel.
Keratin/keratinization A squamous pearl or a maturing sheet or ball of stratified (± palisading!) epithelium is an easily recognized feature of SqCC. Usually 
the cytoplasm is glassy, pink, and intercellular bridges are present. The individual cell with keratinization has an intact nucleus with 
eosinophilic ring around the nucleus and correlate with perinuclear tonofibrillar bundles ultrastructurally. This may be tricky and 
prone to over interpretation, i.e., pyknotic nuclei with dense eosinophilic cytoplasm cannot be used for identification of individual 
cell keratinization. Individual cell death (apoptosis) can be falsely interpreted as keratinization.
Individual cell keratinization is beside pearl formation and intercellular bridges also defining for squamous differentiation.
Intercellular gaps Intercellular gaps are quite a common finding in many lung cancers, which is mostly an artifact, representing fixation and processing 
changes. It is a change which is often misinterpreted as indicating squamous differentiation, probably because gaps are needed 
to see bridges and so, pathologists can “see”—maybe actually imagine—bridges when gaps are present. Image 2 show lots of 
gaps where there are no intercellular bridges and the impression is that the gaps without bridges are wide, uneven, and variable. 
Sometimes there is little or no cytoplasm apparent between the nucleus and the gap.
Intercellular gaps are not diagnostic for squamous cell or other carcinomas.
Intracytoplasmic 
vacuoles
Vacuoles are according to Stedman’s Medical Dictionary, defined as a “clear space in the substance of a cell, sometimes degenerative 
in nature.” Vacuoles may hint at the possibility of an adenocarcinoma but never define or confirm the diagnosis—and may be seen 
in all sorts of tumors as degenerative changes. Vacuoles might trigger a mucin stain—the mucin stain may confirm adenocarcinoma 
differentiation. For the purpose of this study with intracytoplasmic vacuoles those vacuoles are meant, which may have a high chance 
to be positive in the mucin stain, see Figure 3. Vacuoles can be round, oval or odd shapes and their location in the cell is not of much 
help. Mucin stain is less likely to be positive if there were multiple vacuoles and just beneath the cell membrane and more likely to be 
positive if single, big and look as if they had something in them. In essence vacuoles are frequently seen in any carcinoma, but those 
which are more frequently associated with mucin positivity open the possibility of adenocarcinoma (solid type).
Palisading Palisading is defined as layer of relatively long cells with nuclei arranged loosely perpendicular to a surface and parallel to each 
other. Palisading is not a defining feature of SqCC and is seen in other tumors (i.e., basaloid carcinoma, adenocarcinomas and 
neuroendocrine carcinomas). However, in the correct context, it might be useful to raise the possibility of SqCC, assuming other 
features are present. There was no consensus on what was exactly meant with this feature, Figure 4.
Lymphocytic  
infiltrate
Lymphocytes occur regularly in stroma of NSCLC. In LELC, an appreciable number of intratumoral lymphocytes are present: i.e., in 
the nest between tumor cells, Figure 5. Small numbers get ignored. In Eastern countries, EBV is usually positive, but in Western 
countries usually negative. The LELC may become defined by the presence of EBV. For the purpose of this study, the presence and 
location of the lymphocytes were recorded.
Sheets of  
polygonal cells
Sheets or nests of polygonal cells are a characteristic of epithelial architecture, see Figure 1. In case of a malignant tumor, it is pointing 
toward a carcinoma instead of sarcoma or lymphoma. “Sheets of polygonal cells” is thus not restricted to SqCC. In larger areas of 
sarcomatoid carcinoma, sheets are usually lacking.
Spindle cells According to the WHO 2004, a spindle cell carcinoma “consists of only spindle-shaped cells,” architecturally nests/fascicles with 
overtly malignant nuclear features (Fig. 6). As for calling, a case sarcomatoid carcinoma unanimous consensus was present in case 
of diffuse mesenchymal spindle appearance of the tumor, this pattern was used for designation of "spindle.”
Whereas with some spindle-like cells in more nested tumors (mixed with epitheloid nuclei), the variation was much larger.
Glassy eosinophilic 
cytoplasm
Is an eosinophilic cytoplasm, which is not unique to SqCC carcinoma, but is frequently present when defining criteria for SqCC were 
also present. Eosinophilic cytoplasm may also occur in adenocarcinomas, especially in invasive areas.
Giant cells No consensus
Nuclear moulding Nuclear moulding is a frequent finding in small-cell lung carcinoma, but a rare feature in SqCCs. However, it may occasionally be 
present in small-cell type SqCC.
SqCC, squamous cell carcinoma; NSCLC, non–small-cell lung cancer; LELC, lymphoepithelial-like carcinoma; WHO, World Health Organization.
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example, SqCC (criteria 1–3 in Table 1 with at least one “yes”) 
and for p63/40 positivity was computed, as well as Youden’s J 
statistic (the sum of the sensitivity and specificity minus 1). The 
same was undertaken for the sensitivity, specificity, and Youden’s J 
statistic for a positive score for intracytoplasmic vacuoles (“yes”) 
and for thyroid transcription factor/mucin positivity. Associations 
between the two categorical variables were tested by the χ2 test.
For statistical analysis, the SPSS software package ver-
sion 20.0 (IBM Corp., Armonk, NY) was used.
RESULTS
Descriptions of Histological Criteria
Detailed descriptions for the interpretation of histological 
criteria were made (Table 2 and Figs. 2–7). To assess the reproduc-
ibility of poorly differentiated NSCLC, 16 pathologists read 37 
cases. The original contributors’ diagnoses were SqCC (n = 13), 
basaloid carcinoma (n = 5), AdC solid type (n = 4), large cell car-
cinoma (n = 6), sarcomatoid carcinoma (n = 5), and LELC (n = 4).
In nine cases, the presence of “keratinization” was 
scored by a majority of pathologists (mean, 83%; range, 
62–94%), while in the other 28 cases, on an average, one 
pathologist (mean, 4%; range, 0–25%) scored “keratiniza-
tion” as being present. In six of these first nine cases, “pearl 
formation” was also scored as being present by the majority of 
the pathologists (mean, 63%; range, 25–88%). “Intercellular 
bridges” were also seen in seven of these nine cases by the 
majority (mean, 74%; range, 25–94%), while these features 
were rarely scored in the other 26 cases. Thus, only a minor-
ity of the 37 cases consisted of SqCC according to the read-
ers. “Intercellular gaps” were scored as being present slightly 
more often in the cases with keratinization, as compared to 
the others, suggesting that this feature is not specific for this 
differential diagnosis.
To establish consistency in the use of the histological 
criteria, the relation between scored histological criteria and 
specific diagnosis provided by the same observer is shown in 
Table 3. In general, the three squamous cell criteria (keratiniza-
tion, squamous pearls, and intercellular bridges) were scored 
present in 17 to 25% of all the scores (n = 592: 16 pathologists × 
37 cases). These three criteria were highly correlated (r > 0.50, 
data not shown) and mainly distributed over SqCC and sarco-
matoid carcinoma. In these sarcomatoid carcinomas, an area of 
SqCC was present according to the original diagnosis.
“Sheets of polygonal cells” and “intercellular gaps” 
were scored as present in 85% and 58%, respectively, scored 
in all diagnostic categories, but mainly distributed over SqCC 
and large cell carcinoma. “Peripheral palisading of the nuclei,” 
“glassy eosinophilic cytoplasm,” “spindle cells,” and “giant 
cells” were scored in SqCC and large cell carcinoma. “Glassy 
eosinophilic cytoplasm” and “spindle cells” were also scored in 
sarcomatoid carcinoma. “Giant cells” were frequently scored in 
sarcomatoid carcinoma. “Nuclear moulding” was rarely scored 
(12%), but when present, was seen in SqCC, basaloid, and large 
cell carcinoma. Lymphocytes in stroma were present in 80% of 
the scores, and lymphocytes admixed amongst the tumor cells 
in 35%. The score for “intracytoplasmic vacuoles” was 22%, 
distributed over large cell carcinoma, SqCC, and AdC.
Additional Stains and Criteria
In cases with submitted diagnosis of SqCC, additional 
stains for AdC differentiation (TTF1/mucin) and p63/40 were 
FIgURE 1.  A flow chart for the 
application of histological criteria in 
poorly differentiated SqCC based on 
the WHO classification 2004.1 HPF, 
high power field; NUT, NUT midline 
carcinoma, family member 1 (NUTM1); 
SqCC, squamous cell carcinoma; 
WHO, World Health Organization.
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requested in 73% and 78% of the cases, respectively. For the 
other diagnoses, this fraction was higher with 91 and 92%, 
respectively, indicating the relatively undifferentiated mor-
phology of these latter cases, as well as, the wish for immuno-
histochemical information in these cases.
In Table 4, the relation between the scored histological cri-
teria and additional stains for AdC (TTF1 and mucin) and SqCC 
is shown. In general, the squamous cell criteria are usually scored 
as present in cases positive for p63/p40, and not scored as pres-
ent when AdC stains were positive (for all p < 0.001). A similar 
finding was shown for palisading of the nuclei. Intracytoplasmic 
vacuoles scored as present were more frequently associated with 
positive AdC differentiation stains and less frequently with posi-
tive p63/p40. The remaining criteria did not show a significant 
relation with these additional stains.
Observer’s Diagnosis Compared to 
Diagnosis of Submitting Pathologist
The distribution of original diagnosis from submitting 
pathologist compared to diagnosis of 16 pathologists is shown 
for two different levels in Table 5. The first level is based on 
hematoxylin and eosin (H&E) only and the second level on 
H&E combined with information from the additional stains: 
p63/p40, TTF1, and/or mucin. The overall κ score (95% confi-
dence interval [CI]) at the first level was 0.31 (eight categories, 
95% CI, 0.23–0.40), and increased to 0.45 (seven categories, 
95% CI, 0.37–0.53) at the second level, showing an essential 
improvement with the use of additional stains.
Reproducibility of Diagnostic Categories
In Table 6, the κ scores for each individual diagnostic cat-
egory versus all other categories combined are shown. For most 
individual categories, the κ score improved (or remained above 
0.46) with the use of additional stains, in the case of SqCC, solid 
AdC, sarcomatoid carcinoma, and LELC. For basaloid carci-
noma, adenosquamous carcinoma, and large cell carcinoma, the 
κ score remained below 0.30 after the use of additional stains.
Interobserver Variation Criteria Related to  
Additional Stains
For each pathologist, the relation between the presence 
of H&E features of squamous differentiation and p63/40 was 
TAbLE 3.  The Histologic Criteria Scored to Be Present (n/% of Positive Scores) for the Diagnosis of the Same Observer Is 
Shown, Plus Sum of These Scores and % of Total Scores (Total = 592)
Diagnosis SqCC Basaloid AdC Ad.SqC LCC Sarc. LELC Total % Total
Keratinization 109 2 0 1 5 21 0 138 23%
79% 1% 0% 1% 4% 15% 0%
Pearl formation 74 2 0 1 4 18 0 99 17%
75% 2% 0% 1% 4% 18% 0%
Intercellular bridges 122 1 0 0 5 20 0 148 25%
82% 1% 0% 0% 3% 14% 0%
Intercellular gaps 140 14 16 1 130 34 6 341 58%
41% 4% 5% 0% 38% 10% 2%
Peripheral palisading nuclei 67 24 6 0 51 6 0 154 26%
44% 16% 4% 0% 33% 4% 0%
LI between tumor cells 3 0 3 0 13 3 3 25 4%
12% 0% 12% 0% 52% 12% 12%
LI in stroma 116 21 14 1 127 15 0 294 49%
39% 7% 5% 1% 43% 5%
LI in both compartments 40 3 12 1 93 14 22 185 31%
22% 2% 6% 1% 50% 8% 12%
Sheets polygonal cells 152 22 27 2 244 39 19 505 85%
30% 4% 5% 0% 48% 8% 4%
Spindle cells 35 3 6 1 39 43 0 127 21%
28% 2% 5% 1% 31% 34% 0%
Giant cells 32 0 4 0 30 23 0 89 15%
36% 0% 4% 0% 34% 26% 0%
Glassy eosinophilic cytoplasm 112 3 7 2 83 27 2 236 40%
47% 1% 3% 1% 35% 11% 1%
Intracytoplasmic vacuoles 23 0 18 1 75 10 1 128 22%
18% 0% 14% 1% 59% 8% 1%
Nuclear moulding 10 16 2 1 40 2 0 71 12%
14% 23% 3% 1% 56% 3% 0%
SqCC, squamous cell carcinoma; Basaloid, basaloid carcinoma; AdC, adenocarcinoma; Ad.SqC, adenosquamous carcinoma; LCC, large cell carcinoma; Sarc, sarcomatoid 
carcinoma; LELC, lymphoepithelial-like carcinoma; LI, lymphocytes.
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similar: the mean and SD of the observers’ sum of sensitivity and 
specificity were 133 ± 13%. The ideal maximum is the sum of 
100% sensitivity and 100% specificity = 200%. For the presence 
of intracytoplasmic vacuoles and TTF1/mucin positivity, these 
values were 115 ± 17%. These data emphasize that more informa-
tion about differentiation is obtained in undifferentiated or poorly 
differentiated tumors with the use of additional stains, than is rec-
ognized by light microscopic criteria alone in H&E-stained slides.
TAbLE 4.  Relation between a Score of “Yes” for Individual Criteria (n and %) and TTF1 (Total Scores n = 576) and p63/p40 
(Total Scores = 560)
TTF1 and/or Mucin p63/p40
Negative Positive Negative Positive
Criterion n % n % p Value n % n % p Value
Keratinization 132 29% 6 5% <0.001 2 2% 134 31% <0.001
Pearl formation 94 21% 5 4% <0.001 1 1% 97 22% <0.001
Intercellular bridges 139 31% 9 7% <0.001 7 5% 139 32% <0.001
Intercellular gaps 284 63% 61 48% 0.001 81 63% 254 59% 0.36
Peripheral palisading of nuclei 136 30% 21 16% 0.002 20 16% 136 31% <0.001
Sheets polygonal cells 392 88% 110 86% 0.64 109 85% 379 88% 0.44
Spindle cells 95 21% 32 25% 0.36 32 25% 80 19% 0.11
Giant cells 74 17% 16 13% 0.27 23 18% 60 14% 0.25
Glassy eosinophilic cytoplasm 185 41% 58 45% 0.42 59 46% 180 42% 0.37
Intracytoplasmic vacuoles 78 17% 42 33% <0.001 36 28% 79 18% 0.02
Nuclear moulding 63 14% 9 7% 0.03 16 13% 55 13% 0.94
TAbLE 5.  The Original Diagnosis of Submitting Pathologist Is Compared to Diagnosis (in %) of 16 Pathologists Based on H&E 
only and Including Information Additional Stains (p63/p40, TTF1, Mucin)
Diagnosis
Original Diagnosis
SqCC Basal Adeno LCC Sarcom. LELC
% % % % % %
H&E only SqCC 59% 11% 9% 11% 20% 9%
Basaloid 2% 24% 0% 7% 0% 0%
AdC 0% 1% 33% 6% 5% 3%
AdenoSqmC 0% 1% 2% 0% 0% 0%
LCC 33% 55% 52% 65% 28% 56%
Sarcom. 2% 1% 0% 5% 48% 0%
LELC 2% 0% 2% 2% 0% 28%
DD SqCC-AdC 2% 6% 3% 3% 0% 3%
Total 100% 100% 100% 100% 100% 100%
H&E plus stains SqCC 76% 31% 3% 19% 13% 14%
Basaloid 4% 33% 0% 14% 0% 0%
AdC 0% 1% 70% 8% 10% 8%
AdenoSqmC 0% 6% 2% 1% 0% 2%
LCC-Sqcc 10% 19% 3% 19% 1% 14%
LCC-AdC 0% 1% 11% 7% 9% 5%
LCC-AdenoSqmC 0% 3% 8% 2% 3% 0%
LCC-undiff 4% 6% 2% 22% 5% 28%
Sarcom. 2% 0% 0% 6% 60% 0%
LELC 3% 0% 2% 2% 0% 30%
Total 100% 100% 100% 100% 100% 100%
SqCC, squamous cell carcinoma; Basaloid, basaloid carcinoma; AdC, adenocarcinoma; AdenoSqmC, adenosquamous carcinoma; LCC, large cell carcinoma; Sarcom., sarcomatoid 
carcinoma; LELC, lymphoepithelial-like carcinoma; DD SqCC-AdC, combination of SqCC and adenocarcinomas in the differential diagnosis; LCC-SqCC, large cell carcinoma favor 
SqCC; LCC-AdC, large cell carcinoma favor adenocarcinoma, LCC-Adenosquameus carcinoma; LCC-undiff, large cell carcinoma, additional stains negative.
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DISCUSSION
Histologic criteria are consistently used by patholo-
gists according to WHO criteria1, but in poorly differentiated 
cases of NCSLC, many may not be present and the definitions 
are subject to individual interpretation, rendering consistent 
diagnosis more difficult and raising the possibility of a range 
of differential diagnoses based on cytological pleomorphism 
rather than aspects of differentiation. Also, this study dem-
onstrates that, with the use of ancillary stains in poorly dif-
ferentiated NSCLC, improved reproducibility can be obtained 
for the histopathological categories SqCC, solid AdC, sar-
comatoid carcinoma, and LELC. Furthermore, it highlights 
the need for more precise definitions of individual histologic 
criteria, something evidenced in earlier studies relating to the 
definition of invasion.3
In relation to ancillary stains, the reproducibility 
between pathologists in poorly differentiated lung cancer has 
been shown to be poor in the past,10,11 indicating that in H&E 
stained sections, diagnostic criteria are harder to find and may 
increase the likelihood of diagnosis of large cell carcinoma in 
resection specimens. There are numerous publications show-
ing that the addition of IHC reduces the NOS rate in biopsy 
and also may potentially reclassify the number of cases termed 
LCC,12–17 but our data additionally suggest that applying the 
current criteria and practice would lead to higher κ values in 
daily practice than on H&E alone, especially in these more 
poorly differentiated tumors.7
However, it is important to realize that these additional 
staining criteria do not have a defining capacity by them-
selves, as these stains are neither 100% specific nor sensitive. 
p63 may stain some AdCs, and TTF1 has a sensitivity of 70 
to 80% in AdCs, plus both antibodies may stain tumors from 
other sites. Nevertheless, in the context of tumors where clas-
sification comes down to the differential of more poorly dif-
ferentiated NSCLCs, these stains provide ancillary data that 
improve the accuracy of pathological diagnosis.
The consistent use of histological criteria is essential for 
histopathological diagnosis. In our study, the first phases of 
the study uncovered variations in interpretation of the indi-
vidual criteria and we, therefore, made slightly stricter defini-
tions (Table 2) even though some of the defining SqCC criteria 
(keratinization, squamous pearls, and intercellular bridges) 
originated 5 decades ago.18 Again, this highlights the impor-
tance of ensuring that the written definitions are open to as 
little variation in interpretation as possible.
Even with stricter definitions, some criteria were found 
to be problematic in relation to the distinction of SqCCs from 
other subgroups. These included the term “intercellular gaps,” 
which some pathologists were misinterpreting as the “intercel-
lular bridges” of true squamous differentiation. Furthermore, 
“glassy eosinophilic cytoplasm” may also be recognized in 
AdCs and large cell carcinomas with mucin or TTF1 posi-
tivity and may reflect what some have termed “pseudo-squa-
moid” morphology.19 Neither of these criteria appear to be of 
value in histologic distinction on H&E staining. Furthermore, 
the architectural terms “sheets of cells” may have a limited 
descriptive value in the distinction of epithelioid tumors from 
sarcomatoid tumors, but otherwise has little diagnostic value 
in the subtyping of NSCLCs.
Conversely, cytological criteria such as “spindle cells” in 
the context of a diffuse pattern with fascicles reached consensus 
and were of value in the classification of sarcomatoid carcino-
mas, although they were described in cases classified by some as 
SqCC. This, therefore, highlights the importance in document-
ing evidence of both squamoid and AdC differentiation in these 
more poorly differentiated epithelial tumors that are showing 
increased cellular plasticity. Moreover, the presence of sarcoma-
toid areas in greater than10% renders the diagnosis of sarcoma-
toid carcinoma and trumps squamous cell or AdC (Fig. 1).1
Despite some histological criteria being shown to have 
diagnostic value in more poorly differentiated tumors, our 
study shows that there is considerable overlap in these features 
that are helpful, for recognition of certain subtypes and are 
also discerned in the others. The examples are: features such 
as “intracytoplasmic vacuoles” which were scored as being 
present in cases finally classified as both SqCC and large cell 
carcinoma. Some of these may reflect a lack of mucin stains. 
Recently, the presence of two mucin droplets, instead of five 
in two high power fields was shown to be sufficient for diag-
nosis of AdC.8 Moreover, recognition of these features is also 
dependent on having a good quality, well stained section of the 
correct thickness to examine.
TAbLE 6.  Kappa Score (Two Categories: Specific Category vs. the Others; 95% Confidence Interval in Brackets) for Diagnostic 
Categories Based on (1) H&E Diagnosis Alone and on (2) Stains: Diagnosis Including Information Additional Stains (p63/p40, 
TTf1, Mucin)
SqCC Basaloid AdC AdenoSqmC LCC Sarcom. LELC
H&E 0.46 (0.33–0.59) 0.27 (0.19–0.36) 0.21 (0.10–0.33) 0.05 (0.0–0.19) 0.25 (0.15–0.36) 0.52 (0.35–0.69) 0.56 (0.36–0.76)
H&E + stains 0.46 (0.33–0.59) 0.25 (0.16–0.34) 0.53 (0.33–0.73) 0.09 (0.0–0.19) Rangea (0.12–0.21) 0.52 (0.34–0.69) 0.47 (0.34–0.60)
Combining categories
H&E 0.36 (0.25–0.48) 0.21 (0.10–0.33) 0.05 (0.0–0.10) 0.25 (0.15–0.36) 0.52 (0.35–0.69) 0.56 (0.36–0.76)
H&E + stains 0.57 (0.45–0.70) 0.63 (0.46–0.81) 0.20 (0.10–0.29) 0.21 (0.04–0.38) 0.52 (0.34–0.69) 0.47 (0.34–0.60)
After combining two diagnostic categories κ scores were recalculated. For this SqCC and basaloid was defined as one category; large cell carcinoma favoring SqCC was combined 
with SqCC; large cell carcinoma, favoring AdC with adenocarcinoma; large cell carcinoma, favoring AdenoSqmC to AdenoSqCC. Large cell carcinoma, unclassified after stains 
remained the large cell category.
SqCC, squamous cell carcinoma; Basaloid, basaloid carcinoma; AdC, adenocarcinoma; AdenoSqmC, adenosquamous carcinoma; LCC, large cell carcinoma; Sarcom., sarcomatoid 
carcinoma; LELC, lymphoepithelial like carcinoma.
aRange for the following categories: large cell carcinoma, favoring SqCC; large cell carcinoma, favoring AdenoC; large cell carcinoma, favoring AdenoSqCC; large cell carcinoma, 
unclassified.
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Basaloid carcinoma was described in 1992. The cardi-
nal histopathologic features distinguishing this tumor from 
the other NSCLCs are a lobular growth pattern of small 
cells with moderately hyperchromatic nuclei without promi-
nent nucleoli, and with scant cytoplasm, a high mitotic rate, 
and peripheral palisading.20 This pattern could be present in 
a pure form or mixed with SqCC and was associated with 
a poor prognosis in stage I cases when compared to other 
NSCLCs.21 When the prognosis of basaloid carcinomas is 
compared to poorly differentiated SqCCs, however, no differ-
ences were found, although the case numbers in these studies 
were relatively small.22,23 In many instances, the differential 
diagnosis includes SCLC small-cell lung cancer and large cell 
neuroendocrine carcinoma (LCNEC).24–27 Additional staining 
showing positive 34βE12 and p63 may suggest a diagnosis of 
basaloid SqCC. Taking the additional information from this 
study into account, arguments exist to consider basaloid carci-
noma as a variant of SqCC. In this instance, IHC is superim-
posable with this interpretation.
Limitations of this study are that (1) the reader had 
only one section in images to examine, whereas the submis-
sion diagnosis was based on all the sections on glass slides 
A B
C D
E F G
H I
J K
FIgURE 2.  Example of consen-
sus squamous cell carcinoma. A, 
Overview, ×20 (B), example of 
spindle cells in diffuse architecture 
(no nests or fields) (C), consensus 
score for lymphocytic infiltrate 
between the tumor cells (D), For 
palisading, no consensus was 
obtained: 25% of the pathologists 
called this palisading (E), detailed 
images with around the centered 
cell in at least part of the perime-
ter features of intercellular bridges 
(F, G), detailed images with three 
examples of intercellular gaps 
(called by most pathologists) 
(H–J), example of intracytoplasmic 
vacuole (arrow, consensus by all 
the pathologists) (K).
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available; (2) IHC outcome was used and not the reproduc-
ibility of IHC interpretation; (3) images were scanned at ×20 
magnification, making interpretation of subtle morphologic 
features at ×40 less optimal.
In conclusion, the histologic criteria that may be used 
in the differential diagnosis of poorly differentiated lung can-
cer need to be more precisely refined. Furthermore, additional 
stains improve the reproducibility of histological diagnosis of 
SqCC and AdC, uncovering information that is not present in 
regular H&E-stained slides.
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